Search Results 91-100 of 17977 for monoclonal antibody
Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. ... Monoclonal antibodies, such as obinutuzumab, may ...
Monoclonal antibodies, such as nivolumab, may interfere with the ability of ... No history of severe hypersensitivity to a monoclonal antibody. Signed ...
Monoclonal antibodies, such as obinutuzumab, may interfere with the ability ... Rituximab is a monoclonal antibody that may interfere with the ability of cancer ...
Bortezomib may also stop the growth of cancer cells by blocking blood flow to the tumor. Monoclonal antibodies, such as rituximab, can block cancer growth ...
Clinical outcome trials study the use of human monoclonal antibodies to target biochemical pathways that impact LDL receptor availability and monoclonal ...
Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving ...
Monoclonal antibodies, such ... Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin.
In other words, people getting an injection of monoclonal antibodies and being protected for the next 90 plus days. Dr. Halena Gazelka 19:52. How interesting.
Monoclonal antibodies mimic the antibodies your body naturally produces as ... The monoclonal antibody solanezumab did not demonstrate any benefit for ...
... monoclonal antibody;; The relative lack of awareness by patients and providers of the availability of such therapeutic options; and; The fact that such use of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.